Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2004 Dec;1(3):e60.
doi: 10.1371/journal.pmed.0010060.

A taxpayer-funded clinical trials registry and results database

Erick H Turner  1
Affiliations
Editorial

A taxpayer-funded clinical trials registry and results database

Erick H Turner. PLoS Med. 2004 Dec.

Abstract

It already exists within the US Food and Drug Administration, argues a former clinical reviewer of psychotropic drugs at the FDA

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The author is on the speaker's bureaus of Eli Lilly, AstraZeneca, and Bristol-Myers Squibb. He has provided outside consulting to Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, and Sepracor. He has also received funding for clinical drug trials, which can be spent only for research purposes and which has no effect on his income, from Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, and DOV Pharmaceuticals.

Figures

None
The public would benefi t from more freedom of information at the FDA
(Illustration: Margaret Shear)
See this image and copyright information in PMC

Comment in

  • A Canadian perspective.
    Till JE. Till JE. PLoS Med. 2005 Mar;2(3):e83. doi: 10.1371/journal.pmed.0020083. Epub 2005 Mar 29. PLoS Med. 2005. PMID: 15783265 Free PMC article. No abstract available.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Chan AW, Hrobjartsson A, Haahr MT, Gotzsche PC, Altman DG. Empirical evidence for selective reporting of outcomes in randomized trials: Comparison of protocols to published articles. JAMA. 2004;291:2457–2465. - PubMed
    1. Dickersin K. How important is publication bias? A synthesis of available data. AIDS Educ Prev. 1997;9(Suppl 1):15–21. - PubMed
    1. Martinez B. Spitzer charges Glaxo concealed Paxil data. Wall Street Journal. 2004. Jun 3, p. 1. Sect B.
    1. Dickersin K, Rennie D. Registering clinical trials. JAMA. 2003;290:516–523. - PubMed
    1. Derbis J, Toigo T, Woods J, Evelyn B, Banks D. FDAMA section 113: Information program on clinical trials for serious and life-threatening diseases [poster]. Ninth Annual FDA Science Forum; 2003 April 24; Washington, D. C. 2003.

Publication types

MeSH terms